Liminatus Pharma, Inc. Warrants (LIMNW) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.02M | -386.85K | -600.61K | -8.98M | -159.39K | -785.5K | -729.36K | -687.89K | -903.72K | -627.1K | -539.35K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -1164.35% | 50.75% | 17.65% | -1204.84% | 82.36% | -25.26% | -35.23% | - | - | - | - |
| Net Income | -1.12M | -8.17M | -1.82M | 113.29K | -255 | -868.31K | -642.9K | -534.85K | -858.23K | -486.6K | -323.89K |
| Depreciation & Amortization | 518 | 543 | 542 | 743 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.21K |
| Other Non-Cash Items | 4.18K | 15.27M | 1.1M | -1.6M | 0 | 205.71K | -481.71K | -112.01K | 130.63K | -169.7K | -376.03K |
| Working Capital Changes | -896.27K | -7.49M | 119.07K | -7.49M | 255 | -122.89K | 395.25K | -41.03K | -176.12K | 29.2K | 157.35K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 9.3K | 0 | 10.9K | 19.1M | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 23.06K | -2.01M | 0 | 0 | 0 | -18.04K | 0 | 75.77M | 0 | 0 |
| Cash from Investing | 0 | 0 | -13.11K | -775K | -575K | -57.34K | 485.53K | 1.29M | 248.83M | -42.7K | 10.75M |
| Capital Expenditures | 0 | 0 | -13.11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -775K | 0 | 0 | -1.8M | 537.2K | 1.27M | 248.83K | -853.26K | 853.26K |
| Cash from Financing | 3.59M | 0 | 0 | 11.03M | 713K | 550K | 262.8K | -465.67K | 700K | 488.5K | -9.99M |
| Debt Issued (Net) | 0 | 0 | 0 | 3.04M | 713K | 550K | 800K | 800K | 700K | 488.5K | 370K |
| Equity Issued (Net) | 3.59M | 0 | -2.56M | 10.56M | 0 | 1.8B | -537.2K | -1.27M | 0 | 10.66B | -10.36M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -537.2K | -1.27M | 0 | 10.66B | -10.36M |
| Other Financing | 0 | 0 | 2.56M | -2.56M | 0 | 0 | 0 | 0 | 0 | -10.66B | 0 |
| Net Change in Cash | 1.57M | -386.85K | -613.72K | 1.34M | -21.39K | 446.36K | 18.98K | -1.13M | 45.11M | -181.3K | 222.54K |
| Free Cash Flow | -2.02M | -386.85K | -613.72K | -8.98M | -159.39K | -785.5K | -729.36K | -687.89K | -903.72K | -627.1K | -539.35K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -1164.35% | 50.75% | 15.86% | -1204.84% | 82.36% | -25.26% | -35.23% | - | - | - | - |
| FCF per Share | -0.08 | -0.02 | -0.02 | -0.39 | -0.01 | -0.11 | -0.10 | -0.10 | -0.12 | -0.09 | -0.07 |
| FCF Conversion (FCF/Net Income) | 1.79x | 0.05x | 0.33x | -79.23x | 625.07x | 0.90x | 1.13x | 1.29x | 0.52x | 1.29x | 1.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 271.83M | -193.84M | 0 |